Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
2007
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer
2019 StandoutNobel
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial
2012
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer
2004
Quantifying the role of PSA screening in the US prostate cancer mortality decline
2007
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
1995
Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial
2015
The current and potential role of hyperthermia in radiotherapy
1989
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome
2005
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Phase III Multi-Institutional Trial of Adjuvant Chemotherapy With Paclitaxel, Estramustine, and Oral Etoposide Combined With Long-Term Androgen Suppression Therapy and Radiotherapy Versus Long-Term Androgen Suppression Plus Radiotherapy Alone for High-Risk Prostate Cancer: Preliminary Toxicity Analysis of RTOG 99-02
2008
Interpreting Trends in Prostate Cancer Incidence and Mortality in the Five Nordic Countries
2007
Endosonographic Evaluation of the Patient With Esophageal Cancer
1997
Heating the patient: a promising approach?
2002 Standout
Cancer statistics, 2013
2013 Standout
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials
1996
The rising prevalence of androgen deprivation among older American men since the advent of prostate‐specific antigen testing: a population‐based cohort study
2006
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
2011
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Androgen‐deprivation therapy as primary treatment for localized prostate cancer
2006
The use of hormonal therapy with radiotherapy for prostate cancer: analysis of prospective randomised trials
2004
Current Status of HIFU and Cryotherapy in Prostate Cancer – A Review
2006
Population‐based 10‐year oncologic outcomes after low‐dose‐rate brachytherapy for low‐risk and intermediate‐risk prostate cancer
2012
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
2009
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Cancer immunotherapy via dendritic cells
2012 Standout
Long-term results of interstitial brachytherapy (LDR-Brachytherapy) in the treatment of patients with prostate cancer
2006
Esophageal Cancer
2003 Standout
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
2008
Osteoporosis: now and the future
2011 Standout
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
2005 Standout
Is there a prostate‐specific antigen upper limit for radical prostatectomy?
2011
Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: Prognostic factors in 196 tumors
1998
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
2005
Global cancer statistics
2011 Standout
Duration of Androgen Suppression in the Treatment of Prostate Cancer
2009
Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer
2008
Graves' Ophthalmopathy
2010 Standout
Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix
1997
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Outcome Predictors of Radical Prostatectomy in Patients With Prostate-Specific Antigen Greater Than 20 ng/ml: A European Multi-Institutional Study of 712 Patients
2010
Lack of Benefit for the Addition of Androgen Deprivation Therapy to Dose-Escalated Radiotherapy in the Treatment of Intermediate- and High-Risk Prostate Cancer
2010
A head and neck hyperthermia applicator: Theoretical antenna array design
2007
EAU Guidelines on Prostate Cancer
2007 Standout
Cancer statistics, 2012
2012 Standout
Clinical experience using 8 MHZ radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase study
1995
Effect of hyperthermia on the central nervous system: A review
1994
Low dose reirradiation in combination with hyperthermia: A palliative treatment for patients with breast cancer recurring in previously irradiated areas
1988
Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
2008
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer
2007
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
2010
Cancer immunotherapy comes of age
2011 StandoutNature
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Risk of Fracture after Androgen Deprivation for Prostate Cancer
2005
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
2006
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
2009
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
2007
Cancer Mortality Surveillance--United States, 1990-2000
2004
The relevance of a hypoxic tumour microenvironment in prostate cancer
2009
An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions
2007
Outcome of Surgery for Clinical Unilateral T3a Prostate Cancer: A Single-Institution Experience
2006
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology
2010
The Natural History of Noncastrate Metastatic Prostate Cancer after Radical Prostatectomy
2006
Combined radiation and hyperthermia: Effects of the number of heat fractions and their interval on normal and tumour tissues
1992
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: a prospective randomized clinical trial
1988
TRAIL-mediated signaling in prostate, bladder and renal cancer
2011
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
2000
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610
2008
Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
2009
Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
2008
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
2005
Clinical applications of N-acetylcysteine.
1998
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer
2008
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
2002
Cancer treatment and survivorship statistics, 2016
2016 Standout
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Defining High Risk Prostate Cancer With Risk Groups and Nomograms: Implications for Designing Clinical Trials
2006
Cancer statistics, 2014
2014 Standout
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Adjuvant Weekly Docetaxel for Patients With High Risk Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Pilot Study
2007
Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy
2004
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
2006
Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02
2003
Management of Graves' Ophthalmopathy: Reality and Perspectives
2000
Works of L.E.C.M. Blank being referenced
Effect of N-acetylcysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung tumor cells
1989
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
2004
Chestwall recurrences of breast cancer: Results of combined treatment with radiation and hyperthermia
1988
ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer
2000
Results of Deep Body Hyperthermia with Large Waveguide Radiators
1990
Staging and prognosis using endosonography in patients with inoperable esophageal carcinoma treated with combined intraluminal and external irradiation
1994
Analysis of Biopsy Findings and Implant Quality following Ultrasonically‐guided 125 l Implantation for Localised Prostatic Carcinoma
1993
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Combined treatment with radiation and hyperthermia inmetastatic malignant melanoma
1986
Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy
1996